| 20100042526 | Credit-debit-chargecard and identity theft fraud prevention method - A new method of fraud prevention for lost, stolen, cloned or on-file creditcards, debitcards and chargecards. This same method will prevent fraudulent transfer of funds from on-line or off-line bank accounts and will prevent the establishment of creditlines or loans in the name of an unwitting consumer. Furthermore, this method can prevent unauthorized accessing of secured computer sites. The method comprises a pre-determined dedicated telephone terminal data-base which is interfaced and/or in communication with: normally closed credit-debit-charge card funding approvalsa; normally blocked banking transactions; normally unauthorized creditline or loan approval; normally inaccessable secured computer sites whereby a consumer-cardholder-subscriber can call the said dedicated telephone terminal database and together with a pre-determined authentication means can open, authorize, approve or access the normally closed/denied operations outlined above for a pre-determined number of transactions and/or time limit just before using them. After transaction(s) and/or time limit expires the open-approval condition will default to the closed-denial mode where it will continue until consumer-cardholder-subscriber wants to re-open the above operations temporarily for his/her own use. It should be obvious that fraud perpetrators will never know when these operations will be activated for brief periods of time and therefore will not be able to perpetrate the fraud. The additional authentication required for the consumer-cardholder-subscriber can be a personal identification number (PIN) and/or password and/or telephone number identification means and/or biometric means especially voice recognition identification on the telephone. | 02-18-2010 |
| 20100086530 | Cancer-tumor necrosis by artery nutrient-oxygen blocking - This is a new, novel, natural, relatively non-invasive and non-toxic method for the shrinkage and necrosis of cancerous cells, tumors, glands, organs, metastases processes or unwanted growths in human or animal patients. A patient's or other donor's blood is aged and processed which results in the loss of its blood vessel dilating component, nitric oxide. In addition to the loss of the vessel dilating component the other components of the blood become stiffer, stickier and sludgier. This processed blood is to then be directed by injection or catheter into the newly formed, fine, fragile, deranged and disorganized micro-capillaries of the patients cancerous tumors or unwanted growths or into the arteries that feed them nutrients and oxygen. The processed blood blocks, clogs or clots these super-fine micro-vessels and their wasteline pathways thereby causing the cancerous tumors or unwanted growths to shrink and die. The processed, aged or modified blood can also be used in combination with a blood separating hemapheresic means which can separate out the nitric oxide and/or any other components which would make the blocking blood more fluid or less viscous and can also be used immediately without further aging. In addition, the hemapheresic means can also separate other blocking components of the blood such as artery plaque building agents which together with the nitric oxide depleted blood will more readily block the unwanted growths micro-capillaries. Some or all of the unused components of the hemapheresic separated blood can be returned to the donor, harvested for future use or discarded. The method can also be used periodically to control or treat the condition if no cure is possible. Furthermore, the method can be used on many other chronic conditions which require new blood vessel formation to cause and/or sustain them. Finally, these methods can also be used in combination or conjunction with other therapies, procedures and protocols that seek the same end result for possible synergistic advantages. | 04-08-2010 |
